CFO Moves this week include:
|Flotek Industries, Inc.||Second Sight Medical Products, Inc.||MOVE Guides|
|Heidrick & Struggles International, Inc.||Tintri, Inc.||Zpower|
|Sienna Biopharmaceuticals, Inc.||Spirit Realty Capital, Inc.||Rogers Corporation|
|Simon||Johnson & Johnson||CareSource|
|Amblin Partners||C&J Energy Services, Inc.||Nanophase Technologies Corporation|
|LGS Innovations||OUTFRONT Media Inc.||Change Healthcare|
|Sorrento Therapeutics, Inc.||gr8 People Inc.||Touchstone Bank|
|Workfront||TriCore Reference Laboratories||NeoGenomics, Inc.|
Would you like to receive our weekly CFO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any CFO Moves to report, please email us.
NOTE: CFO Search Report available monthly to CFOs only. Read more here.
CFO Moves is published by Samuel Dergel (Executive Search Consultant and CFO & Financial Executive Search Specialist with Dergel Executive Search). Samuel can be reached by email at email@example.com or by phone at +1 (415) 738-2070.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Flotek Industries, Inc. [HOUSTON] (NYSE: FTK) announced that Matthew Marietta has been promoted to Executive Vice President of Finance & Corporate Development and will serve as the Company’s principal financial officer. Matt joined Flotek in March 2017 and previously served as Senior Vice President of Corporate Development and Investor Relations. Prior to joining Flotek, Mr. Marietta was a publishing sell-side analyst for Stephens, Inc. His experience includes finance, accounting and strategic planning roles at Exterran, Forestar Group and XTO Energy.
Second Sight Medical Products, Inc. [SYLMAR, Calif.] (NASDAQ: EYES) announced that John T. Blake has been appointed Chief Financial Officer. Mr. Blake succeeds Thomas Miller, who has served as Chief Financial Officer since 2014. In June 2017, Mr. Miller submitted his resignation to pursue other opportunities but agreed at our request to remain in the position until his successor was named. Mr. Blake most recently served as Senior Vice President, Finance of aTyr Pharma, a company he joined in March 2015. Prior to aTyr, Mr. Blake was responsible for the global financial planning and analysis function at Volcano Corporation (Volcano), March 2010 to March 2015 and as the SEC Reporting Manager from November 2008 through March 2010. Mr. Blake was also previously an auditor in public accounting and an analyst for BD Biosciences.
MOVE Guides [SAN FRANCISCO] announced the hiring of Susan Repo as its Chief Financial Officer. Repo comes to MOVE Guides from Tesla, Inc. where she was Corporate Treasurer and Vice President of Finance. Her broad experience includes key financial positions at Juniper Networks, Agilent Technologies, KPMG LLP, and Ernst & Young LLP, among others.
Heidrick & Struggles International, Inc. [Chicago, IL] announced that Mark Harris was appointed to serve as the Chief Financial Officer. He replaces Richard Pehlke, who is retiring. Mr. Harris has been serving as the Deputy Chief Financial Officer of the Company since February 2018. Since 2015, Mr. Harris had been Chief Financial Officer at Hercules Capital. Prior to that, Mr. Harris worked at Avenue Capital Group for over 8 years, where he served as their Chief Financial Officer for their Asia Strategy and was their Senior Managing Director/Head of Asia. Prior to working at Avenue Capital Group, from 2004 to 2006 Mr. Harris served as Corporate Financial Controller and Chief Accounting Officer at Hutchinson Telecommunications.
ZPower [CAMARILLO, CALIF.] announced the appointment of Dennis Dugan to Chief Financial Officer. Mr. Dugan previously served as VP of Accounting & FP&A for ZPower. Prior to joining ZPower, Mr. Dugan worked as a Controller for Implant Direct, Inc. Before that role, he was the Chief Financial Officer for Nutiva, Inc. He has also worked as Chief Financial Officer for Advanced Structured Alloys, Inc.; Corporate Controller for Abrisa Industrial; Plant Controller for Pentair; and Vice President of Finance / Controller for Joslyn Electronic Systems and Pacific Scientific in the Electronic Kinetics Division.
Sienna Biopharmaceuticals, Inc. [WESTLAKE VILLAGE, Calif.] (NASDAQ: SNNA) announced the appointment of John W. Smither as the Company’s Chief Financial Officer. Mr. Smither will succeed Richard Peterson, who has resigned for personal reasons. Mr. Smither served as Sienna’s CFO from January 2016 to March 2017, and subsequently has served as an independent consultant in the biopharmaceutical industry. Previously, he served as CFO of Kythera Biopharmaceuticals, Inc. from November 2007. From 1998 to 2007, Mr. Smither held various positions at Amgen. From 2001 to 2004, he served as vice president of finance and administration for Amgen’s European Division. Prior to that, Mr. Smither served as head of internal audit, and following his time in Europe was executive director of corporate accounting. Prior to joining Amgen, he served as audit partner at Ernst & Young LLP, and following his time at Ernst & Young served as CFO of several early stage companies. Mr. Smither has served on the board of directors of Achaogen, Inc. since December 2013, where he currently serves as the audit committee chair and a member of the compensation committee.
Spirit Realty Capital, Inc. [DALLAS] (NYSE: SRC) announced that Michael Hughes has been named to the position of Executive Vice President and Chief Financial Officer. Mr. Hughes replaces outgoing Chief Financial Officer Phil Joseph. In addition, the Company announced that Ricardo Rodriguez has been appointed to the role of Chief Financial Officer at Spirit MTA REIT. Most recently, Mr. Hughes was Executive Vice President, Chief Financial Officer at FelCor Lodging Trust, from 2013 through 2017. Prior to that, he held various roles in corporate finance at FelCor from 2006 to 2013, and held multiple roles at Wyndham Hotels Corporation from 2002 to 2006, most recently as Vice President, Corporate Finance. Mr. Rodriguez joins Spirit Master Trust from Morgan Stanley, where he had 17 years of experience, most recently as Executive Director – Global Capital Markets in the Structured Solutions Group.
Johnson & Johnson [NEW BRUNSWICK, N.J.] (NYSE: JNJ) announced that Joseph Wolk, Vice President of Johnson & Johnson Investor Relations, has been appointed Executive Vice President, Chief Financial Officer. He replaces Dominic J. Caruso, who has elected to retire, after a distinguished 19-year career with the Company. Caruso was named CFO in 2007, and served as CFO longer than anyone in the company’s 132- year history. Mr. Wolk has been with Johnson & Johnson for 19 years and has served on the Finance Leadership team, since 2014. Previously, he was Vice President, Finance and CFO of the Janssen Pharmaceutical Companies of Johnson & Johnson and was a member of the Janssen Group Operating Committee. Prior to this role, he held many senior roles in Pharmaceuticals, Medical Device and Supply Chain.
CareSource [DAYTON, Ohio] announced the appointment of new Chief Financial Officer David Goltz. He replaces former CFO Tarlton Thomas, who was recently promoted to Chief Operating Officer. Goltz most recently served as Chief Financial Officer of Emerging Markets for Health Care Services Corporation. Goltz joins the organization following the shift of two core team positions.
Amblin Partners [UNIVERSAL CITY, Calif.] announced that Christina Leotis has been named Chief Financial Officer. She replaces Lyndsay Harding, who as previously announced, is leaving the company. Leotis comes to Amblin from the LA Clippers organization where she served as CFO. Prior to joining the Clippers, Leotis held senior financial management positions at Fox Networks Group, Concord Music and Otter Media. She began her career in Dallas, Texas, at Bain & Company, followed by a position at Goldman Sachs. She then became a member of the acquisitions team at Colony Capital.
C&J Energy Services, Inc. [HOUSTON] (NYSE: CJ) announced that Mark Cashiola, C&J’s Chief Financial Officer (“CFO”), has resigned to pursue other opportunities. Mike Galvan, currently C&J’s Senior Vice President and Chief Accounting Officer, will assume the additional role of CFO on an interim basis until a replacement is appointed. Mr. Galvan joined the Company in 2014 as part of the financial leadership team working with the CFO. He has approximately 25 years of accounting and financial experience and, among other duties.
Nanophase Technologies Corporation [ROMEOVILLE, Ill.] (OTCQB: NANX) announced that the Company has hired Jaime Escobar to serve as its Chief Financial Officer. Prior to becoming a member of the Nanophase team, Mr. Escobar held positions in a series of manufacturing companies with consistently expanding responsibilities. Most recently, he served as Controller of CGW, and has also had significant experience as Controller of Amcol HBS.
LGS Innovations [HERNDON, Va.] has appointed Jeff Beck as Executive Vice President and Chief Financial Officer (EVP-CFO). Mr. Beck’s appointment follows the retirement of EVP-CFO John Fitzgerald. Mr. Beck Over has thirty years of government contracting related experience, including more than twenty years in a Chief Financial Officer role. Prior to joining LGS, Mr. Beck served as the CFO for DRS Technologies, Inc.’s C4ISR Group. Mr. Beck has also held CFO and related finance management positions with QinetiQ North America, STG Inc., Getronics Government Solutions, Raytheon, and Lockheed Martin.
OUTFRONT Media Inc. [NEW YORK] (NYSE: OUT) announced that Donald R. Shassian, Executive Vice President and Chief Financial Officer, will retire from the company. Shassian joined the Company in November 2013.
Change Healthcare [NASHVILLE, Tenn.] announced the appointment of Fredrik Eliasson as executive vice president and chief financial officer. Mr. Eliasson joins Change Healthcare after a 20-year career at CSX Corporation, where he served as executive vice president and chief financial officer, as well as chief sales and marketing officer. Mr. Eliasson has held numerous financial leadership roles including serving as director of investor relations, vice president of commercial finance and vice president of financial planning and analysis. Mr. Eliasson also served in many other senior leadership roles at CSX, including vice president of Emerging Markets and vice president of Chemicals and Fertilizer.
Sorrento Therapeutics, Inc. [SAN DIEGO] (NASDAQ: SRNE) announced that it appointed Jiong Shao as Executive Vice President and Chief Financial Officer. From 2015 to 2017, Jiong served as Managing Director, Head of China Technology, Internet, and Media (TIM) investment banking at Deutsche Bank in Hong Kong. Prior to that time, from 2010 to 2015, he held various Managing Director positions at Macquarie Capital including Head of China TIM investment banking and Head of pan-Asia TIM research, also in Hong Kong. Jiong started his investment banking career with Lehman Brothers in New York as an equity research analyst.
gr8 People Inc. [PHILADELPHIA] announced the appointment of Rachael McCarthy as their new Chief Financial Officer. Ms. McCarthy was most recently the CFO of CloudLock Inc., and has held various senior management roles, including Chief Financial Officer, General Counsel and Vice President of Business Development. She has worked in fast growing software and SaaS companies, including General Counsel of two software companies (Unica Corporation and Restrac/WebHire, Inc.) from very early stages through their initial public offerings.
Touchstone Bank [MCKENNEY, Va.] (OTC Pink: TSBA) announced the appointment of Vera H. Primm as Chief Financial Officer, a position that was previously served by Philip Cardwell. Ms. Primm previously served her most recent tenure as Chief Financial of Citizens Community Bank and previously at Bank of Virginia, Peoples Bank of Virginia and F&M Bank-Richmond.
Workfront [SILICON SLOPES, Utah] announced that Jon Pexton has joined the company as chief financial officer (CFO). He was previously CFO of Progrexion. He also previously served as CFO of Interbank FX, and held leadership positions at Callidus Software, Vitria Technology and Remedy Corporation. He also spent eight years with Ernst & Young working in their audit, tax, and transaction advisory practices.
TriCore Reference Laboratories [Albuquerque, New Mexico] announced Renee Ennis as Chief Financial Officer. Ms. Ennis will replace TriCore’s current CFO, Kent Gordon, who will be leaving to pursue new opportunities. Ms. Ennis served as TriCore’s CFO for 10 years before moving to Presbyterian Healthcare Services where she currently serves as Vice President and CFO of PDS.
NeoGenomics, Inc. [FT. MYERS, FL] announced the appointment of Sharon Virag as Chief Financial Officer. Ms. Virag will succeed George Cardoza, who has served as Chief Financial Officer since 2009. Sharon Virag was formerly Vice President, Corporate Finance and Chief Accounting Officer, at Aetna. Prior to Aetna, between 2008 and 2015, Ms. Virag held various positions in Finance, including: Chief Accounting Officer of AES Corp., Global Controller for several General Electric businesses in the U.S. and overseas, and Assistant Corporate Controller at General Motors. In addition to her private sector experience, Ms. Virag worked for the Public Company Accounting Oversight Board (“PCAOB”) from 2005 to 2008, where she served as the project leader for Auditing Standard No. 5, the Board’s requirements/regulations for Sarbanes-Oxley Section 404. She also worked in public accounting for Deloitte & Touche, LLP where she was an Audit Senior Manager. Ms. Virag is also a member of the Financial Accounting Standards Advisory Council (FASAC).